Dupixent Lawsuit in Wyoming - Free Case Review

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Key Takeaway

Wyoming, the nation's least populous state with approximately 580,000 residents, supports an estimated 4,000 Dupixent patients since 2017. The state's limited specialist infrastructure means many Dupixent patients receive care through Cheyenne Regional Medical Center, Wyoming Medical Center (Casper), or travel to Denver, Salt Lake City, or Billings for specialty dermatology. Wyoming lacks an NCI-designated cancer center, and CTCL evaluation requires referral to out-of-state academic centers — typically the Huntsman Cancer Institute (Salt Lake City) or the University of Colorado Cancer Center (Denver). Wyoming's 4-year statute of limitations for product liability is among the most generous, and the state's absence of compensatory damage caps is plaintiff-favorable. The District of Wyoming handles minimal pharmaceutical litigation, and most cases will benefit from MDL coordination. Wyoming's independent, frontier-minded jury pools are unpredictable in pharmaceutical cases but tend to value individual liberty and distrust corporate overreach.

Written By

People's Justice Legal Research Team

Statute of Limitations

Wyoming: 4 years for product liability (Wyo. Stat. Ann. § 1-3-105(a)(iv)(C)). Discovery rule applies — the limitations period begins when the plaintiff discovers or should have discovered the injury and its connection to the product.

4 years from discovery of injury

Filing Venue

Where to File in Wyoming

Wyoming has a single federal judicial district — the District of Wyoming, headquartered in Cheyenne and Casper. Wyoming follows a modified comparative fault system (51 percent bar) and does not cap compensatory damages in product liability cases. Wyoming's small population and limited legal community mean most pharmaceutical cases involve out-of-state counsel.

Wyoming Data

Exposure in Wyoming

Source: IQVIA prescription data estimates

Source: National Cancer Institute

Source: Wyo. Stat. Ann. § 1-3-105

FAQ

Frequently Asked Questions

See details below.

Back to Dupixent Lawsuit Lawsuit Overview